Real-life anti-vascular endothelial growth factor treatment for age-related macular degeneration and diabetic macular edema in an Italian tertiary referral hospital.

CONCLUSIONS: Our study described the 2-year real-life outcome of anti-vascular endothelial growth factor treatment of diabetic macular edema and age-related macular degeneration. PMID: 31617403 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31617403?dopt=Abstract

Source: European Journal of Ophthalmology - October 15, 2019 Category: Opthalmology Authors: Battaglia Parodi M, Romano F, Arrigo A, Sacchi R, Scanzi G, Ferri C, Bandello F Tags: Eur J Ophthalmol Source Type: research